Nostrum Biodiscovery
Nostrum Biodiscovery is a biotech spin-off from the Barcelona Supercomputing Center and the Institute for Research in Biomedicine, specializing in AI-powered molecular design and advanced molecular modeling technologies. The company focuses on therapeutics, including small molecules, targeted protein degradation, antibodies, immunologics, nucleic acids, and bio-based chemistry such as enzyme engineering. Their proprietary platform, including the PELE Monte-Carlo molecular modeling algorithm and AI tools, enables efficient screening, de novo design, and optimization of molecules. Nostrum offers customer-tailored solutions through services, licensing, and co-development, serving clients in over 12 countries with expansion in the US, Asia, and Latin America. The company is recognized for innovation, scientific excellence, and strong international presence in computational drug discovery and molecular design.
Nostrum Biodiscovery
Nostrum Biodiscovery is a biotech spin-off from the Barcelona Supercomputing Center and the Institute for Research in Biomedicine, specializing in AI-powered molecular design and advanced molecular modeling technologies. The company focuses on therapeutics, including small molecules, targeted protein degradation, antibodies, immunologics, nucleic acids, and bio-based chemistry such as enzyme engineering. Their proprietary platform, including the PELE Monte-Carlo molecular modeling algorithm and AI tools, enables efficient screening, de novo design, and optimization of molecules. Nostrum offers customer-tailored solutions through services, licensing, and co-development, serving clients in over 12 countries with expansion in the US, Asia, and Latin America. The company is recognized for innovation, scientific excellence, and strong international presence in computational drug discovery and molecular design.